Rituximab and donor lymphocyte infusions are an effective salvage treatment for B-cell lymphoma relapsing after reduced-intensity allogeneic stem cell transplantation

被引：0
|
作者：
Spina, F. [1 ]
Patriarca, F. [2 ]
Farina, L.
Montefusco, V.
Dodero, A.
Carniti, C.
Fanin, R. [2 ]
Corradini, P. [1 ]
机构：
[1] Univ Studi Milano, Ist Nazl Tumori, Fondaz IRCCS, Milan, Italy
[2] Azienda Ospedaliero Univ Santa Maria Misericordia, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S245 / S246
页数：2
相关论文
共 50 条
  • [21] Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation
    Cavattoni, Irene
    Zabelina, Tatjana
    Ayuk, Francis
    Wolschke, Christine
    Bacher, Ulrike
    Zander, Axel
    Kroeger, Nicolaus
    LEUKEMIA & LYMPHOMA, 2010, 51 (01) : 146 - 148
  • [22] Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Devetten, Marcel P.
    Hari, Parameswaran N.
    Carreras, Jeanette
    Logan, Brent R.
    van Besien, Koen
    Bredeson, Christopher N.
    Freytes, Cesar O.
    Gale, Robert Peter
    Gibson, John
    Giralt, Sergio A.
    Goldstein, Steven C.
    Gupta, Vikas
    Marks, David I.
    Maziorz, Richard T.
    Vase, Julie M.
    Lazarus, Hillard M.
    Anderlini, Paolo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (01) : 109 - 117
  • [23] Donor lymphocyte infusions for the treatment of relapse after allogeneic hematopoietic stem cell transplantation.
    Riera, L
    Koziner, B
    MEDICINA-BUENOS AIRES, 2000, 60 (02) : 259 - 269
  • [24] Fatal leukoencephalopathy after reduced-intensity allogeneic stem cell transplantation
    Mielke, Stephan
    Potthoff, Karin
    Feuerhake, Friedrich
    Bley, Thorsten A.
    Windfuhr, Marisa
    Bertz, Hartmut
    Finke, Juergen
    ONKOLOGIE, 2007, 30 (1-2): : 49 - 52
  • [25] Allogeneic stem cell transplantation with reduced-intensity conditioning in patients with relapsed lymphoma
    Rivas, M.
    Berro, M.
    Belaustegui, S.
    Prates, V.
    Yantorno, S.
    Milone, J.
    Remaggi, G.
    Rolon, J. Martinez
    Milone, G.
    Basquiera, A.
    Garcia, J.
    Sturich, G.
    Kusminsky, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S257 - S258
  • [26] Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes
    Peggs, Karl S.
    Sureda, Anna
    Qian, Wendi
    Caballero, Dolores
    Hunter, Ann
    Urbano-Ispizua, Alvaro
    Cavet, James
    Ribera, Josep M.
    Parker, Anne
    Canales, Miguel
    Mahendra, Premini
    Garcia-Conde, Javier
    Milligan, Donald
    Sanz, Guillermo
    Thomson, Kirsty
    Arranz, Reyes
    Goldstone, Anthony H.
    Alvarez, Ivan
    Linch, David C.
    Sierra, Jorge
    Mackinnon, Stephen
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (01) : 70 - 80
  • [27] Effective immunotherapy of resistant indolent lymphoma/CLL by reduced-intensity allogeneic stem cell transplantation (SCT)
    Nickelsen, M
    Ritgen, M
    Humpe, A
    Döhner, H
    Stilgenbauer, S
    Seyfarth, B
    Glass, B
    Truemper, L
    Schoch, R
    Schmitz, N
    Dreger, P
    BONE MARROW TRANSPLANTATION, 2002, 29 : S150 - S150
  • [28] Reduced intensity conditioning allogeneic stem cell transplantation) as salvage treatment for relapsing multiple myeloma (MM): A donor vs. no donor comparison
    de Lavallade, H.
    Ladaique, P.
    Faucher, C.
    Furst, S.
    El Cheikh, J.
    Stoppa, A. M.
    Coso, D.
    Bouabdallah, R.
    Vey, N.
    Sainty, D.
    Chabannon, C.
    Gastaut, J. A.
    Blaise, D.
    Mohty, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 169 - 169
  • [29] T-Cell-Depleted Reduced-Intensity Conditioning Transplantation for Lymphoma: Do Donor Lymphocyte Infusions Really Matter?
    van Besien, Koen
    Kenkre, Vaishalee
    Artz, Andrew S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : E243 - E243
  • [30] Host Lymphocyte Depletion as a Strategy to Facilitate Early Full Donor Chimerism after Reduced-Intensity Allogeneic Stem Cell Transplantation
    Salit, Rachel B.
    Fowler, Daniel H.
    Dean, Robert M.
    Pavletic, Steven Z.
    Hakim, Frances T.
    Steinberg, Seth M.
    Hardy, Nancy T.
    Sportes, Claude
    Gress, Ronald E.
    Bishop, Michael R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (10) : 1509 - 1513
12345